1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Chronic Pain Management Clinical Research Award (PMCCRA) is sponsored by Defense Health Agency Contracting Activity - DHACA (U.S. Department of Defense). This award supports large-scale pragmatic comparative effectiveness and implementation science clinical trials that will facilitate the acceptance and utilization of evidence-based chronic pain management clinical applications, such as health care products, technologies, clinica…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.
gov Maintenance Calendar DOD Chronic Pain Management, Pain Management Collaborative Clinical Research Award Defense Health Agency Contracting Activity - DHACA Document Type:Grants Notice Funding Opportunity Number:HT9425-23-CPMRP-PMCCRA Funding Opportunity Title:DOD Chronic Pain Management, Pain Management Collaborative Clinical Research Award Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Grant Category of Funding Activity:Science and Technology and other Research and Development Expected Number of Awards:1 Assistance Listings:12.
420 -- Military Medical Research and Development Cost Sharing or Matching Requirement:No Last Updated Date:Jul 03, 2023 Original Closing Date for Applications:Nov 09, 2023 Current Closing Date for Applications:Nov 09, 2023 Archive Date:Dec 09, 2023 Estimated Total Program Funding:$ 5,600,000 Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Additional Information on Eligibility: ## Additional Information Agency Name:Defense Health Agency Contracting Activity - DHACA Description:The intent of the FY23 CPMRP PMCCRA is to support large-scale pragmatic comparative effectiveness and implementation science clinical trials that will facilitate the acceptance and utilization of evidence-based chronic pain management clinical applications, such as health care products, technologies, clinical practice guidelines, and/or models of care.
PMCCRA applications should explain how the proposed work will inform the development, refinement, and/or revision of existing standards of care, recommendations, or guidelines for managing chronic pain. Military and Veterans health care systems and other health care entities that provide services to Service Members, Veterans, and their families are the targeted organizations for this program.
Research conducted in partnership with eligible VA and Military Health System (MHS) providers is essential for obtaining meaningful and relevant research results in “real world” health care delivery systems serving Veterans, Service Members, and their beneficiaries.
Applications to the FY23 CPMRP PMCCRA are aligned with appropriations specifically intended for chronic pain research, therefore, all applications to the funding opportunity must address chronic pain either alone or in the context of common comorbidities. Applications primarily focused on comorbid conditions (e.g., TBI, depression, posttraumatic stress disorder [PTSD]) are not appropriate for the FY23 CPMRP PMCCRA.
Studies seeking to advance new and novel opioid-based therapeutic interventions do not meet the intent of this DOD FY23 Chronic Pain Management award mechanism and will not be selected for funding. Studies seeking to understand and reduce opioid utilization in chronic pain management within the context of current prescribing practices are acceptable. Funding from this award mechanism must support a clinical trial.
A clinical trial is defined as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. For more information, a Human Subject Resource Document is provided at https://cdmrp. health.
mil/pubs/pdf/Human%20Subjects%20Resource%20Document. pdf. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.
The FY23 CPMRP PMCCRA mechanism supports implementation science and/or comparative effectiveness research. Clinical trials under these Focus Areas should be restricted to pain management interventions that have already been shown to be efficacious in some clinical settings. Studies seeking to evaluate new therapies or approaches, either pharmacological or non-pharmacological, do not meet the intent of the award mechanism.
Applicants seeking funding for a clinical trial of novel treatments or untested approaches to chronic pain management are encouraged to consider the FY23 Clinical Exploration Award.
The FY23 CPMRP PMCCRA is designed to be a phased award comprised of a 15-month planning phase award performance period intended for the completion of activities required to initiate the planned clinical trial (e.g., obtaining regulatory approvals, finalizing of collection tools and common data elements (CDEs), study site onboarding and activation).
Execution of the full-scale clinical trial will be considered an optional second phase research effort. Link to Additional Information:[](https://www. grants.
gov/search-results-detail/349080) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes. To continue working, click on the "OK" button below. This is being done to protect your privacy.
Unsaved changes will be lost.
According to the current listing, eligibility includes: Military and Veterans health care systems and other health care entities that provide services to Service Members, Veterans, and their families. Confirm the full requirements in the official notice before applying.
Chronic Pain Management Clinical Research Award (PMCCRA) is funded by Defense Health Agency Contracting Activity - DHACA (U.S. Department of Defense). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
HEAL Initiative: Integrative Management of Chronic Pain and Opioid Use Disorder (OUD) for Whole Recovery: Health Systems (RM1 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). This NOFO will develop strategies to address barriers to the sustainable and effective delivery of integrated OUD/pain care at the health systems level.
HEAL Initiative: Integrative Management of Chronic Pain and Opioid Use Disorder (OUD) for Whole Recovery: Health Systems is sponsored by National Institutes of Health (NIH) - HEAL Initiative (NIDA, NIAAA, NIAMS, NIMH, NCCIH, NINDS). This NOFO will develop strategies to address barriers to the sustainable and effective delivery of integrated OUD/pain care at the health systems level, building upon previous HEAL IMPOWR efforts that identified effective patient-level interventions.
HEAL Initiative: Integrative Management of Chronic Pain and Opioid Use Disorder (OUD) for Whole Recovery: Health Systems is sponsored by National Institutes of Health (NIH). This NOFO encourages research applications to develop strategies to address barriers to the sustainable and effective delivery of integrated opioid use disorder (OUD) and chronic pain care at the health systems level.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article